#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Glucose management indicator (GMI) and its relationship to glycated haemoglobin


Authors: A. Frühaufová 1;  P. Krollová 2;  J. Urbanová 3;  J. Michalec 2;  J. Brož 2
Authors‘ workplace: Oddělení primární péče FN Motol, Praha, Primář: MUDr. Jaroslava Kulhánková 1;  Interní klinika 2. LF UK a FN Motol, Praha, Přednosta: prof. MUDr. Radan Keil, Ph. D. 2;  Centrum pro výzkum diabetu, metabolismu a výživy, Interní klinika 3. LF UK a FNKV, Praha, Přednosta: prof. MUDr. Ivan Rychlík, CSc., FASN, FERA 3
Published in: Prakt. Lék. 2023; 103(2): 51-54
Category: Reviews

Overview

Continuous glucose monitoring is a significant benefit in care of patients with diabetes. By using CGM systems, a variety of new parameters, such as “glucose management indicator ” (GMI), were established to describe glycaemic control of patients. GMI can in some ways imitate glycated haemoglobin, but is not always easily interchangeable.

Keywords:

continuous glucose monitoring – glycated haemoglobin – glucose management indicator – GMI


Sources

1. Urbanová J, Brunnerová L, Brož J. Hidden MODY – Looking for a Needle in a Haystack. Front Endocrinol (Lausanne) 2018; 9: 355. Dostupné z: https://www.frontiersin.org/articles/10.3389/ fendo.2018.00355/full [cit. 2023-03-19].

2. Urbanová J, Brunerová L, Brož J. Diagnostika MODY v ordinaci praktického lékaře. Prakt. Lék. 2018; 98(4): 153–157.

3. Brož J, Malinovská J, Nunes MA, et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: A cross-sectional study. Diabetes Res Clin Pract 2020; 170: 108470.

4. Brož J, Janíčková Žďárská D, Urbanová J, a kol. Current level of glycemic control and clinical inertia in subjects using insulin for the treatment of type 1 and type 2 diabetes in the Czech Republic and the Slovak Republic: results of a multinational, multicenter, observational survey (DIAINFORM). Diabetes Ther 2018; 9(5): 1897–1906. Dostupné z: https://link.springer.com/ article/10.1007/s13300-018-0485-2 [cit. 2023-03-19].

5. Holubová A, Vlasáková M, Mužík J, Brož J. Customizing the types of technologies used by patients with type 1 diabetes mellitus for diabetes treatment: case series on patient experience. JMIR Mhealth Uhealth 2019; 7(7): e11527. Dostupné z: https://mhealth. jmir.org/2019/7/e11527/ [cit. 2023-03-19].

6. Urbanová J, Holubová A, Taniwall A, a kol. Nový parametr hodnocení kompenzace diabetes mellitus: Čas v cílovém rozmezí (time-in-range). Prakt. Lék. 2021; 101(1): 3–7.

7. Heinemann L. Interferences with CGM systems: practical relevance? J Diabetes Sci Technol 2022; 16(2): 271–274. Dostupné z: https://journals.sagepub.com/doi/10.1177/19322968211065065 [cit. 2023-03-19].

8. Schrangl P, Reiterer F, Heinemann L, et al. Limits to the evaluation of the accuracy of continuous glucose monitoring systems by clinical trials. Biosensors (Basel) 2018; 8(2): 50. Dostupné z: https://www.mdpi.com/2079-6374/8/2/50 [cit. 2023-03-19].

9. Grimsmann JM, von Sengbusch S, Freff M, et al. Glucose Management Indicator based on sensor data and laboratory HbA1c in people with type 1 diabetes from the DPV database: differences by sensor type. Diabetes Care 2020; 43(9): e111–e112. Dostupné z: doi:10.2337/dc20-0259 [cit. 2023-03-19].

10. Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): a new term for estimating a1c from continuous glucose monitoring. Diabetes Care 2018; 41(11): 2275–2280. Dostupné z: doi:10.2337/dc18-1581 [cit. 2023-03-19].

11. Fabris C, Heinemann L, Beck R, et al. Estimation of hemoglobin A1c from continuous glucose monitoring data in individuals with type 1 diabetes: is Time In Range all we need? Diabetes Technol Ther 2020; 22(7): 501–508.

12. Wang M, Hng TM. HbA1c: More than just a number. Aust J Gen Pract 2021; 50(9): 628–632. [cit. 2023-01-17]. Dostupné z: https:// www1.racgp.org.au/ajgp/2021/september/more-than-just-anumber [cit. 2023-03-19].

13. Radin MS. Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med 2014; 29(2): 388–394.

14. Friedecký B, Kratochvíla J, Springer D, a kol. Diabetes mellitus – laboratorní diagnostika a sledování stavu pacientů. Klin Biochem Metab 2019; 27(48): 32–47.

Labels
General practitioner for children and adolescents General practitioner for adults
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#